Abstract
Solid tumors may occasionally regress even without treatment, either spontaneously or as a result of placebo effect. Such spontaneous regressions or responses are intriguing from both scientific and regulatory standpoints. We conducted an updated systematic review and meta-analysis of clinical trials of anticancer drugs in advanced solid tumors to estimate an updated placebo response rate in the targeted therapy/immunotherapy era.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
